{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:43:27Z","timestamp":1720586607263},"reference-count":35,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2019,5,13]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Homocysteine (Hcy) has been suggested as an independent\nrisk factor for atherosclerosis. Apolipoprotein M (apoM) is a constituent of the HDL\nparticles. The goal of this study was to examine the serum levels of homocysteine and\napoM and to determine whether homocysteine influences apoM synthesis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Serum levels of apoM and Hcy in 17 hyperhomocysteinemia (HHcy) patients\nand 19 controls were measured and their correlations were analyzed. Different\nconcentrations of homocysteine (Hcy) and LY294002, a specific phosphoinositide 3-\nkinase (PI3K) inhibitor, were used to treat HepG2 cells. The mRNA levels were\ndetermined by RT-PCR and the apoM protein mass was measured by western blot.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>We found that decreased serum apoM levels corresponded with serum HDL\nlevels in HHcy patients, while the serum apoM levels showed a statistically significant\nnegative correlation with the serum Hcy levels. Moreover, apoM mRNA and protein\nlevels were significantly decreased after the administration of Hcy in HepG2 cells, and\nthis effect could be abolished by addition of LY294002.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>resent study demonstrates that Hcy downregulates the expression of\napoM by mechanisms involving the PI3K signal pathway.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1566524019666190308115624","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T10:54:03Z","timestamp":1552301643000},"page":"120-126","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Negative Correlation Between Serum Levels of Homocysteine and Apolipoprotein M"],"prefix":"10.2174","volume":"19","author":[{"given":"J.","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Comprehensive Laboratory, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Laboratory, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Laboratory, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Laboratory, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Laboratory, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cardiothoracic Surgery, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Clinical Chemistry and Pharmacology, Department of Laboratory Medicine, Lunds University, S-221 85 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Laboratory, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1161\/01.ATV.20.7.1704","volume":"20","author":"Mudd S.H.","year":"2000","unstructured":"Mudd SH, Finkelstein JD, Refsum H. Arterioscler Thromb Vasc Biol, Homocysteine and its disulfide derivatives: a suggested consensus terminology.,, 2000, 20,, 1704-1706,","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0223-5234(03)00113-2","volume":"38","author":"Jansen M.","year":"2003","unstructured":"Jansen M, Dannhardt G. Eur J Med Chem, Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions.,, 2003, 38,, 661-670,","journal-title":"Eur J Med Chem"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1126\/science.143.3613.1443","volume":"143","author":"Mudd S.H.","year":"1964","unstructured":"Mudd SH, Finkelstein JD, Irreverre F. Science, Homocystinuria: An Enzymatic Defect.,, 1964, 143,, 1443-1445,","journal-title":"Science"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"Frosst P.","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R. Nat Genet, A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase.,, 1995, 10,, 111-113,","journal-title":"Nat Genet"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s11064-014-1338-7","volume":"39","author":"Curro M.","year":"2014","unstructured":"Curro M, Gugliandolo A, Gangemi C. Neurochem Res, Toxic effects of mildly elevated homocysteine concentrations in neuronal-like cells.,, 2014, 39,, 1485-1495,","journal-title":"Neurochem Res"},{"key":"ref=6","first-page":"473","volume":"114","author":"Ueland P.M.","year":"1989","unstructured":"Ueland PM, Refsum H. J Lab Clin Med, Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy.,, 1989, 114,, 473-501,","journal-title":"J Lab Clin Med"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/jnc.12615","volume":"129","author":"Abushik P.A.","year":"2014","unstructured":"Abushik PA, Niittykoski M, Giniatullina R. J Neurochem, The role of NMDA and mGluR5 receptors in calcium mobilization and neurotoxicity of homocysteine in trigeminal and cortical neurons and glial cells.,, 2014, 129,, 264-274,","journal-title":"J Neurochem"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1191\/1358863x05vm626oa","volume":"10","author":"Qureshi I.","year":"2005","unstructured":"Qureshi I, Chen H, Brown AT. Vasc Med, Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor.,, 2005, 10,, 215-223,","journal-title":"Vasc Med"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","volume":"324","author":"Clarke R.","year":"1991","unstructured":"Clarke R, Daly L, Robinson K. N Engl J Med, Hyperhomocysteinemia: an independent risk factor for vascular disease.,, 1991, 324,, 1149-1155,","journal-title":"N Engl J Med"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jacc.2011.05.028","volume":"58","author":"Veeranna V.","year":"2011","unstructured":"Veeranna V, Zalawadiya SK, Niraj A. J Am Coll Cardiol, Homocysteine and reclassification of cardiovascular disease risk.,, 2011, 58,, 1025-1033,","journal-title":"J Am Coll Cardiol"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000437098","volume":"67","author":"Lai W.K.","year":"2015","unstructured":"Lai WK, Kan MY. Ann Nutr Metab, Homocysteine-Induced Endothelial Dysfunction.,, 2015, 67,, 1-12,","journal-title":"Ann Nutr Metab"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/jcp.22415","volume":"226","author":"Chiang J.K.","year":"2011","unstructured":"Chiang JK, Sung ML, Yu HR. J Cell Physiol, Homocysteine induces smooth muscle cell proliferation through differential regulation of cyclins A and D1 expression.,, 2011, 226,, 1017-1026,","journal-title":"J Cell Physiol"},{"key":"ref=13","first-page":"1455","volume":"41","author":"Weiss N.","year":"2003","unstructured":"Weiss N, Heydrick SJ, Postea O. Clin Chem Lab Med, Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.,, 2003, 41,, 1455-1461,","journal-title":"Clin Chem Lab Med"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/fcp.12101","volume":"29","author":"Wu S.","year":"2015","unstructured":"Wu S, Gao X, Yang S. Fundam Clin Pharmacol, The role of endoplasmic reticulum stress in endothelial dysfunction induced by homocysteine thiolactone.,, 2015, 29,, 252-259,","journal-title":"Fundam Clin Pharmacol"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","volume":"99","author":"Liao D.","year":"2006","unstructured":"Liao D, Tan H, Hui R. Circ Res, Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.,, 2006, 99,, 598-606,","journal-title":"Circ Res"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12872-016-0186-6","volume":"16","author":"Wang Y.","year":"2016","unstructured":"Wang Y, Liu J, Jiang Y. BMC Cardiovasc Disord, Hyperhomocysteinemia is associated with decreased apolipoprotein AI levels in normal healthy people.,, 2016, 16,, 10-,","journal-title":"BMC Cardiovasc Disord"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.3945\/jn.108.090704","volume":"138","author":"Holven K.B.","year":"2008","unstructured":"Holven KB, Aukrust P, Retterstol K. J Nutr, The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects.,, 2008, 138,, 2070-2075,","journal-title":"J Nutr"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","volume":"384","author":"Rader D.J.","year":"2014","unstructured":"Rader DJ, Hovingh GK. Lancet, HDL and cardiovascular disease.,, 2014, 384,, 618-625,","journal-title":"Lancet"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm1211","volume":"11","author":"Wolfrum C.","year":"2005","unstructured":"Wolfrum C, Poy MN, Stoffel M. Nat Med, Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis.,, 2005, 11,, 418-422,","journal-title":"Nat Med"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1074\/jbc.M704576200","volume":"283","author":"Christoffersen C.","year":"2008","unstructured":"Christoffersen C, Jauhiainen M, Moser M. J Biol Chem, Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice.,, 2008, 283,, 1839-1847,","journal-title":"J Biol Chem"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2011.11.031","volume":"221","author":"Elsoe S.","year":"2012","unstructured":"Elsoe S, Ahnstrom J, Christoffersen C. Atherosclerosis, Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.,, 2012, 221,, 91-97,","journal-title":"Atherosclerosis"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","volume":"108","author":"Christoffersen C.","year":"2011","unstructured":"Christoffersen C, Obinata H, Kumaraswamy SB. Proc Natl Acad Sci USA, Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M.,, 2011, 108,, 9613-9618,","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1042\/bj3520809","volume":"352","author":"Murata N.","year":"2000","unstructured":"Murata N, Sato K, Kon J. Biochem J, Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions.,, 2000, 352,, 809-815,","journal-title":"Biochem J"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"ra79","DOI":"10.1126\/scisignal.aaa2581","volume":"8","author":"Galvani S.","year":"2015","unstructured":"Galvani S, Sanson M, Blaho VA. Sci Signal, HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.,, 2015, 8,, ra79-,","journal-title":"Sci Signal"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12944-017-0458-x","volume":"16","author":"Wei J.","year":"2017","unstructured":"Wei J, Yu Y, Luo GH. Lipids Health Dis, 17beta-estradiol regulates the expression of apolipoprotein M through estrogen receptor alpha-specific binding motif in its promoter.,, 2017, 16,, 66-,","journal-title":"Lipids Health Dis"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbalip.2011.07.003","volume":"1811","author":"Wei J.","year":"2011","unstructured":"Wei J, Shi Y, Zhang X. Biochim Biophys Acta, Estrogen upregulates hepatic apolipoprotein M expression via the estrogen receptor.,, 2011, 1811,, 1146-1151,","journal-title":"Biochim Biophys Acta"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1538-7836.2005.01364.x","volume":"3","author":"Lentz S.R.","year":"2005","unstructured":"Lentz SR. J Thromb Haemost, Mechanisms of homocysteine-induced atherothrombosis.,, 2005, 3,, 1646-1654,","journal-title":"J Thromb Haemost"},{"key":"ref=28","author":"Boushey C.J.","unstructured":"Boushey CJ, Beresford SAA, Omenn GS, , Springer US,, Boston, MA, Edited by Graham I, Refsum H,Rosenberg IH, Ueland PM, Shuman JM., A meta-analysis of plasma homocysteine as a risk factor for arteriosclerotic vascular disease and the potential preventive role of folic acid. In homocysteine metabolism: from basic science to clinical medicine., 1997,245-249","journal-title":"A meta-analysis of plasma homocysteine as a risk factor for arteriosclerotic vascular disease and the potential preventive role of folic acid In homocysteine metabolism: from basic science to clinical medicine"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/17512433.2015.1010516","volume":"8","author":"McCully K.S.","year":"2015","unstructured":"McCully KS. Expert Rev Clin Pharmacol, Homocysteine and the pathogenesis of atherosclerosis.,, 2015, 8,, 211-219,","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.RES.0000204825.66410.0b","volume":"98","author":"Mikael L.G.","year":"2006","unstructured":"Mikael LG, Genest JJR, Rozen R. Circ Res, Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease.,, 2006, 98,, 564-571,","journal-title":"Circ Res"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lfs.2018.10.060","volume":"214","author":"Jin P.","year":"2018","unstructured":"Jin P, Bian Y, Wang K. Life Sci, Homocysteine accelerates atherosclerosis via inhibiting LXRalpha-mediated ABCA1\/ABCG1-dependent cholesterol efflux from macrophages.,, 2018, 214,, 41-50,","journal-title":"Life Sci"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1042\/BST0350188","volume":"35","author":"Downes C.P.","year":"2007","unstructured":"Downes CP, Leslie NR, Batty IH. Biochem Soc Trans, Metabolic switching of PI3K-dependent lipid signals.,, 2007, 35,, 188-192,","journal-title":"Biochem Soc Trans"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/onc.2015.179","volume":"35","author":"Ricoult S.J.","year":"2016","unstructured":"Ricoult SJ, Yecies JL, Ben-Sahra I. Oncogene, Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP.,, 2016, 35,, 1250-1260,","journal-title":"Oncogene"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-9255-6-27","volume":"6","author":"Shastry S.","year":"2009","unstructured":"Shastry S, James LR. J Inflamm (Lond), Homocysteine-induced macrophage inflammatory protein-2 production by glomerular mesangial cells is mediated by PI3 Kinase and p38 MAPK.,, 2009, 6,, 27-,","journal-title":"J Inflamm (Lond)"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbalip.2006.02.002","volume":"1761","author":"Xu N.","year":"2006","unstructured":"Xu N, Ahren B, Jiang J. Biochim Biophys Acta, Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells.,, 2006, 1761,, 256-260,","journal-title":"Biochim Biophys Acta"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T19:58:47Z","timestamp":1560974327000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170566\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,13]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5,13]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566524019666190308115624","relation":{},"ISSN":["1566-5240"],"issn-type":[{"value":"1566-5240","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,13]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}